semaglutide and vomiting Comparative safety side effects of and tirzepatide: Implications for clinical decision-making in obesity management Ozempic: Semaglutide is a GLP-1

10.1002/ijc.23755 71 OdagiriN.MatsubaraT.Sato-MatsubaraM.FujiiH.EnomotoM.KawadaN

Michael Snyder, a bariatric surgeon and obesity specialist, notes that this "leads to early satiety, and making you less likely to drink adequate fluids regularly"

Earlier wearing off

The first reaction involves the enzyme deoxyhypusine synthase which transfers the butylamine moiety from spermidine to the specific eIF-5A lysine residue

The Importance of a Slow and Steady Start The key to a smooth experience with either tirzepatide or semaglutide is starting with a low dose and increasing it slowly

Nearly 90% of obese adults have comorbidities, including metabolic dysfunction-associated fatty liver disease, which affects around 50% of adults with overweight and over 80% of adults with obesity